Novel Drug Delivery Systems in Cancer Therapy Market Analysis By Product (Nanoparticles and Embolization Particles), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2018 - 2025

Table of Contents

Chapter 1 Research Methodology
                 1.1 Information Procurement
                 1.2 Data Analysis
Chapter 2 Executive Summary
                 2.1 Market Snapshot
Chapter 3 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Variables, Trends & Scope
                 3.1 Market Segmentation & Scope
                 3.2 Market Driver Analysis
                     3.2.1 Increasing research on new therapies for cancer backed by research funding
                     3.2.2 Rise in number of cancer cases globally
                         3.2.2.1 Estimated New Cancer Cases, by type, U.S. in 2016
                 3.3 Market Restraint Analysis
                     3.3.1 Lack of awareness and funding for novel drug delivery systems in emerging nations
                 3.4 Penetration & Growth Prospect Mapping
                 3.5 Novel Drug Delivery Devices (NDDS) in Cancer Therapy Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
                 3.6 Industry Analysis - Porter’s
Chapter 4 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Product Estimates & Trend Analysis
                 4.1 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Product Movement Analysis
                 4.2 Nanoparticles
                     4.2.1 Nanoparticles market estimates and forecasts, 2014 - 2025 (USD Million)
                     4.2.2 Liposomes
                         4.2.2.1 Liposomes market estimates and forecasts, 2014 - 2025 (USD Million)
                     4.2.3 Micelles
                         4.2.3.1 Micelles market estimates and forecasts, 2014 - 2025 (USD Million)
                     4.2.4 Polymers
                         4.2.4.1 Polymers market estimates and forecasts, 2014 - 2025 (USD Million)
                     4.2.5 Other nanoparticles
                         4.2.5.1 Other nanoparticles market estimates and forecasts, 2014 - 2025 (USD Million)
                 4.3 Embolization Particles
                     4.3.1 Embolization particles market estimates and forecasts, 2014 - 2025 (USD Million),
                     4.3.2 PVA particles
                         4.3.2.1 PVA particles market estimates and forecasts, 2014 - 2025 (USD Million)
                     4.3.3 Drug eluting beads
                         4.3.3.1 Drug eluting beads market estimates and forecasts, 2014 - 2025 (USD Million)
                     4.3.4 Liquid emboli
                         4.3.4.1 Liquid emboli market estimates and forecasts, 2014 - 2025 (USD Million)
                     4.3.5 Other embolization particles
                         4.3.5.1 Other embolization particles market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Regional Estimates & Trend Analysis, By Product
                 5.1 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Regional Movement Analysis
                 5.2 North America
                     5.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                     5.2.2 U.S.
                         5.2.2.1 Market estimates & forecasts, by product 2014 - 2025 (USD Million)
                     5.2.3 Canada
                         5.2.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                 5.3 Europe
                     5.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                     5.3.2 U.K.
                         5.3.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                     5.3.3 Germany
                         5.3.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                 5.4 Asia Pacific
                     5.4.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                     5.4.2 Japan
                         5.4.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                     5.4.3 China
                         5.4.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                 5.5 Latin America
                     5.5.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                     5.5.2 Brazil
                         5.5.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                     5.5.3 Mexico
                         5.5.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                 5.6 Middle East and Africa (MEA)
                     5.6.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
                     5.6.2 South Africa
                         5.6.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
Chapter 6 Competitive Landscape
                 6.1 List of Market Players
                 6.2 Company Profiles
                     6.2.1 Teva Pharmaceutical Industries Ltd.
                         6.2.1.1 Company overview
                         6.2.1.2 Financial performance
                         6.2.1.3 Product benchmarking
                     6.2.2 Johnson & Johnson Services, Inc.
                         6.2.2.1 Company overview
                         6.2.2.2 Financial performance
                         6.2.2.3 Product benchmarking
                     6.2.3 GALEN
                         6.2.3.1 Company overview
                         6.2.3.2 Financial performance
                         6.2.3.3 Product benchmarking
                         6.2.3.4 Strategic initiatives
                     6.2.4 Merrimack Pharmaceuticals, Inc.
                         6.2.4.1 Company overview
                         6.2.4.2 Financial performance
                         6.2.4.3 Product benchmarking
                         6.2.4.4 Strategic initiatives
                     6.2.5 Shire (Baxalta)
                         6.2.5.1 Company overview
                         6.2.5.2 Financial performance
                         6.2.5.3 Product benchmarking
                     6.2.6 Samyang Biopharmaceuticals Corporation
                         6.2.6.1 Company overview
                         6.2.6.2 Financial performance
                         6.2.6.3 Product benchmarking
                         6.2.6.4 Strategic initiatives
                     6.2.7 Celgene Corporation
                         6.2.7.1 Company overview
                         6.2.7.2 Financial performance
                         6.2.7.3 Product benchmarking
                         6.2.7.4 Strategic initiatives
                     6.2.8 Spectrum Pharmaceuticals, Inc.
                         6.2.8.1 Company overview
                         6.2.8.2 Financial performance
                         6.2.8.3 Product benchmarking
                         6.2.8.4 Strategic initiatives

List of Tables

TABLE 1 North America Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 2 North America nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 3 North America embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 4 U.S. Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 5 U.S. nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 6 U.S. embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 7 Canada Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 8 Canada nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 9 Canada embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 10 Top 10 countries with highest cancer rates,2012
TABLE 11 Europe novel drug delivery systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 12 Europe nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 13 Europe embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 14 U.K. Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 15 U.K. nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 16 U.K. embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 17 Germany Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 18 Germany nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 19 Germany embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 20 Asia Pacific Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 21 Asia Pacific nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 22 Asia Pacific embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 23 Japan Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 24 Japan nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 25 Japan embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 26 China Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 27 China nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 28 China embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 29 Latin America Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 30 Latin America nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 31 Latin America embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 32 Brazil Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 33 Brazil nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 34 Brazil embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 35 Mexico Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 36 Mexico nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 37 Mexico embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 38 MEA Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 39 MEA nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 40 MEA embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 41 South Africa Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
TABLE 42 South Africa nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
TABLE 43 South Africa embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market snapshot (USD Million), 2016
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT Analysis, by factor (Political & legal, economic, and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Product outlook and key takeaways (USD Million)
FIG. 16 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Product movement analysis (USD Million)
FIG. 17 Nanoparticles market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 18 Liposomes market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 19 Micelles market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 20 Polymers market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 21 Other nanoparticles market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 22 Embolization particles market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 23 PVA particles market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 24 Drug-eluting beads market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 25 Liquid emboli market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 26 Other embolization particles market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 27 Regional market place: Key takeaways (USD Million)
FIG. 28 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Regional movement analysis (USD Million)
FIG. 29 North America Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 30 The U.S. Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 31 Canada Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 32 Europe Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 33 U.K. Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 34 Germany Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 35 Asia Pacific Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 36 Japan Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 37 China Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 38 Latin America Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 39 Brazil Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 40 Mexico Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 41 MEA Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
FIG. 42 South Africa Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)